Business Context and Reporting Period
This Form 6-K filing by Farmmi, Inc. covers the month of August 2026. The report addresses two primary corporate events: a notification from Nasdaq regarding a minimum bid price deficiency and the execution of an exchange agreement with Atlas Sciences, LLC.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or total debt levels. The only specific financial figures disclosed relate to a debt restructuring transaction:
- Debt Restructuring: A new promissory note of $200,000 was partitioned from an existing note originally issued on July 30, 2024, with a principal amount of $5,355,000.
- Share Issuance: The Company issued 1,581,027 Class A ordinary shares to satisfy the $200,000 New Note.
Material Changes
The filing details significant changes in the Company's capital structure and listing status:
- Nasdaq Compliance Status: The Company's Class A ordinary shares closed below $1.00 for 30 consecutive business days, triggering a deficiency notice under Nasdaq Listing Rule 5550(a)(2).
- Capital Structure: The Company reduced its outstanding debt by $200,000 through the issuance of new equity, resulting in dilution of existing shareholders.
Guidance, Outlook, and Risks
Compliance Timeline: The Company has a 180-day compliance period ending February 8, 2027, to regain compliance with the $1.00 minimum bid price requirement. Compliance can be achieved if the closing bid price remains at or above $1.00 for 10 consecutive business days or by effecting a reverse stock split.
Delisting Risk: If the Company fails to regain compliance by February 8, 2027, it may be eligible for an additional 180-day grace period, provided it meets other listing standards. Failure to cure the deficiency ultimately subjects the securities to delisting.
Management Commentary: The filing states that the Nasdaq notification does not result in immediate delisting and that shares will continue to trade uninterrupted under the symbol "FAMI."
Investor Verification Checklist
- Verify the current trading price of Class A ordinary shares to assess the likelihood of meeting the $1.00 bid price requirement within the 180-day window.
- Review the full text of the Exchange Agreement (Exhibit 10.1) to understand any remaining terms of the $5,355,000 original note with Atlas Sciences, LLC.
- Monitor for any announcements regarding a potential reverse stock split prior to the February 8, 2027 deadline.
- Check subsequent filings for updates on the Company's ability to meet the market value of publicly held shares requirement if a second grace period is sought.